NCT06419322View on ClinicalTrials.gov

Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).

NAActive, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Spinal Muscular Atrophy
Interventions
OTHER

Optimized rehabilitation program

Consisting of: goal-oriented rehabilitation, hands on physiotherapy sessions and home use of SMA approved rehabilitation device.

Trial Locations (1)

OX3 0BP

Oxford Brookes University, Oxford

Sponsors
All Listed Sponsors
collaborator

Oxford Brookes University

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

collaborator

ACE SMA Charity

UNKNOWN

collaborator

Roche Products Limited

UNKNOWN

collaborator

Scholar Rock, Inc.

INDUSTRY

collaborator

Biohaven Therapeutics Ltd.

INDUSTRY

collaborator

Rally Round Rupert Charity

UNKNOWN

lead

University of Oxford

OTHER

NCT06419322 - Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA). | Biotech Hunter | Biotech Hunter